help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2009.090332 on October 1, 2009

Published online before print October 1, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2009.090332v1
175/5/1929    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Mitchell, C.
Right arrow Articles by Gilgenkrantz, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchell, C.
Right arrow Articles by Gilgenkrantz, H.
(American Journal of Pathology. 2009;175:1929-1937.)
© 2009 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2009.090332

Protection against Hepatocyte Mitochondrial Dysfunction Delays Fibrosis Progression in Mice

Claudia Mitchell*{dagger}, Marie-Anne Robin{ddagger}, Alicia Mayeuf*{dagger}, Meriem Mahrouf-Yorgov*{dagger}, Abdellah Mansouri§, Marie Hamard*{dagger}, Dominique Couton*{dagger}, Bernard Fromenty{ddagger} and Hélène Gilgenkrantz*{dagger}

From the Institut Cochin,* Université Paris Descartes, Centre National de la Recherche Scientifique (Unité Mixte de Recherche 8104), Paris; INSERM, U567,{dagger} Paris; INSERM, U620,{ddagger} Université de Rennes 1, Rennes; and INSERM, U773,§ Centre de Recherche Biomédicale Bichat Beaujon CRB3, Paris, France

Accumulating evidence indicates that oxidative stress is involved in the physiopathology of liver fibrogenesis. However, amid the global context of hepatic oxidative stress, the specific role of hepatocyte mitochondrial dysfunction in the fibrogenic process is still unknown. The aim of this study was to determine whether a targeted protection of hepatocytes against mitochondrial dysfunction could modulate fibrosis progression. We induced liver fibrogenesis by chronic carbon tetrachloride treatment (3 or 6 weeks of biweekly injections) in transgenic mice expressing Bcl-2 in their hepatocytes or in normal control mice. Analyses of mitochondrial DNA, respiratory chain complexes, and lipid peroxidation showed that Bcl-2 transgenic animals were protected against mitochondrial dysfunction and oxidative stress resulting from carbon tetrachloride injury. Picrosirius red staining, {alpha}-smooth muscle actin immunohistochemistry, and real-time PCR for transforming growth factor-β and collagen {alpha}-I revealed that Bcl-2 transgenic mice presented reduced fibrosis at early stages of fibrogenesis. However, at later stages increased nonmitochondrial/nonhepatocytic oxidative stress eventually overcame the capacity of Bcl-2 overexpression to prevent the fibrotic process. In conclusion, we demonstrate for the first time that specific protection against hepatocyte mitochondrial dysfunction plays a preventive role in early stages of fibrogenesis, delaying its onset. However, with the persistence of the aggression, this protection is no longer sufficient to impede fibrosis progression.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society for Investigative Pathology.